Stocks · Healthcare · Medical - Care Facilities
Chemed Corporation CHE
$507.50 +0.91% Close, Oct 2, 2026 · NYSE · Market cap $6.63B
High qualityInexpensive vs sectorLow risk
Next earnings report: Oct 27, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- The diluted share count fell 8.1% in a year, mainly through buybacks.
- The stock is in an uptrend: above its 200-day average for 76 trading days, with the 50-day average above the 200-day.
- The shares trade at 25.5× trailing earnings, lower than 81% of the company's own readings over the past five years.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 36%
- EPS growth (TTM, YoY)Bottom 44%
- FCF growth (TTM, YoY)Bottom 29%
- Revenue growth, 3-year CAGRBottom 40%
- Revenue growth accelerationTop 34%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 5%
- Gross marginBottom 19%
- Operating marginTop 19%
- Cash conversion (OCF / net income)Bottom 42%
- Accruals (lower is better)Top 46%
- Net debt / EBITDA (lower is better)Top 44%
- Interest coverTop 4%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 14%
- Free-cash-flow yieldTop 18%
- EBITDA / enterprise valueTop 19%
- Sales / enterprise valueTop 34%
- P/E vs own 5-year history (lower is better)Top 30%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 48%
- 6-month returnTop 29%
- 1-year return vs S&P 500Top 48%
- Distance from 52-week highTop 14%
- Trend checklist (0–4)Top 39%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 44%
- Consecutive EPS beatsTop 35%
- Share of analysts rating BuyBottom 5%
- Upside to consensus price targetBottom 33%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 2%
- Maximum drawdown, 3 yearsTop 16%
- Beta vs S&P 500 (lower is better)Top 9%
- Net debt / EBITDA (lower is better)Top 44%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 2.1% | 3.3% | ↑ |
| EPS growth (YoY) | -10.7% | 2.3% | ↑ |
| Gross margin | 33.6% | 30.4% | ↓ |
| Operating margin | 14.7% | 13.5% | ↓ |
| FCF margin | 14.8% | 12.5% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 3.3% | 2.1% | ↑ | Bottom 36% |
| EPS growth (TTM, YoY) | 2.3% | -10.7% | ↑ | Bottom 44% |
| Gross margin | 30.4% | 33.6% | ↓ | Bottom 19% |
| Operating margin | 13.5% | 14.7% | ↓ | Top 19% |
| Net margin | 10.6% | 11.6% | ↓ | — |
| Free-cash-flow margin | 12.5% | 14.8% | ↓ | — |
| Return on invested capital | 19.5% | — | Top 5% | |
| Revenue growth, 3-year CAGR | 5.8% | — | Bottom 40% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 1.42×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -7.3%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 0.7%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -1.3 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 0.67×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 72.4×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.50%
- Net buyback yield (TTM)
- 9.65%
- Shareholder yield
- 10.15%
- Share count change, 1 year
- -8.1%
- Share count change, 3-year CAGR
- -4.1%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Jul 31, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 2
- Beats in the last 8 reports
- 4 of 8
- Average EPS surprise, last 4
- +1.0%
- Average 2-day reaction, last 8
- +0.5%
- Positive 20 days after report
- 4 of 8
Analysts
- Consensus price target
- $650.00
- Target vs current price
- +28.1%
- Analysts with a rating
- 9
- Share rating Buy or Strong Buy
- 33%
- Consensus rating
- Hold
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Jul 28, 2026 | +8.2% | +1.6% | +6.1% | +6.3% | — |
| Apr 23, 2026 | +6.6% | +2.6% | +13.6% | +18.3% | +37.7% |
| Feb 25, 2026 | -8.5% | -0.4% | -9.4% | -20.2% | -5.7% |
| Oct 28, 2025 | -2.2% | +0.5% | +0.9% | -0.1% | +2.3% |
| Jul 29, 2025 | -10.7% | -0.3% | -9.2% | -2.2% | -5.4% |
| Apr 23, 2025 | +1.4% | +1.0% | -0.8% | +0.3% | -22.1% |
| Feb 26, 2025 | +0.7% | -0.9% | +6.7% | +10.6% | +3.7% |
| Oct 29, 2024 | -2.1% | +0.2% | -13.8% | -6.0% | -5.6% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Jul 28, 2026 | $6.06 | $5.60 | +8.2% | $673.3M |
| Apr 23, 2026 | $5.65 | $5.30 | +6.6% | $657.5M |
| Feb 25, 2026 | $6.42 | $7.02 | -8.5% | $639.3M |
| Oct 28, 2025 | $5.27 | $5.39 | -2.2% | $624.9M |
| Jul 29, 2025 | $4.27 | $4.78 | -10.7% | $618.8M |
| Apr 23, 2025 | $5.63 | $5.55 | +1.4% | $646.9M |
| Feb 26, 2025 | $6.83 | $6.78 | +0.7% | $640.0M |
| Oct 29, 2024 | $5.64 | $5.76 | -2.1% | $606.2M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 25.5× | 27.9× | 19th | Top 14% |
| P/E (forward) | 19.9× | — | — | — |
| EV / EBITDA | 16.0× | — | — | Top 19% |
| EV / Sales | 2.67× | — | — | Top 34% |
| Free-cash-flow yield | 4.88% | — | — | Top 18% |
| Earnings yield | 3.93% | — | — | Top 14% |
P/E over the past five years
Range 21.2× – 35.0× since Jun 30, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- +15.2%
- Earnings per share growth (TTM)
- +2.3%
- Change in P/E multiple
- +26.2%
Most of the move came from a change in the valuation multiple.
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 76
- 50-day average slope (20 days)
- +1.6%
- 200-day average slope (20 days)
- +1.7%
- Distance from 50-day average
- -3.0%
- Distance from 200-day average
- +11.5%
- RSI (14)
- 46.6
- Relative volume
- 1.01×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 21.2%
- Volatility vs own 5-year history
- 33th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.32
- Correlation with S&P 500
- 0.17
- Current drawdown from 1-year high
- -8.2%
- Maximum drawdown, 3 years
- -43.4%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Mar 19, 2024 | Mar 27, 2026 | -43.4% | 507 days | Not yet recovered |
| Jan 25, 2021 | Oct 11, 2021 | -26.7% | 180 days | 376 days (Apr 11, 2023) |
| Apr 24, 2023 | Sep 8, 2023 | -11.9% | 95 days | 38 days (Nov 1, 2023) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $6.63B
- P/E (TTM)
- 25.5
- EPS, diluted (TTM)
- $19.92
- Revenue (TTM)
- $2.60B
- Dividend yield
- 0.49%
- 52-week range
- $365.21 – $557.00
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $2.14B | $2.13B | $2.26B | $2.43B | $2.53B |
| Gross profit | $769.8M | $765.1M | $798.8M | $854.3M | $758.3M |
| Operating income | $343.0M | $343.5M | $340.6M | $366.5M | $338.2M |
| Net income | $268.6M | $249.6M | $272.5M | $302.0M | $265.2M |
| EPS (diluted) | $16.85 | $16.53 | $17.93 | $19.89 | $18.42 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $606.2M | $640.0M | $646.9M | $618.8M | $624.9M | $639.3M | $657.5M | $673.3M |
| Net income | $75.8M | $90.3M | $71.8M | $52.5M | $64.2M | $76.8M | $66.3M | $67.7M |
| EPS (diluted) | $5.02 | $6.02 | $4.86 | $3.57 | $4.46 | $5.48 | $4.85 | $5.13 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $308.6M | $309.9M | $330.3M | $417.5M | $388.3M |
| Capital expenditure | -$58.7M | -$57.3M | -$56.9M | -$49.5M | -$62.8M |
| Free cash flow | $249.9M | $252.6M | $273.4M | $368.0M | $325.5M |
| Dividends paid | -$22.0M | -$22.0M | -$23.5M | -$27.1M | -$31.7M |
| Net share buybacks | -$576.0M | -$114.5M | -$67.7M | -$361.4M | -$404.3M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $40.2M
- Total assets
- $1.58B
- Total liabilities
- $749.1M
- Total debt
- $329.1M
- Net debt
- $288.9M
- Shareholders’ equity
- $830.5M
As of Jun 30, 2026 (filed Jul 31, 2026).
Dividends
| Ex-date | Amount | Paid |
|---|---|---|
| Aug 17, 2026 | $0.70 | Sep 3, 2026 |
| May 28, 2026 | $0.60 | Jun 16, 2026 |
| Feb 23, 2026 | $0.60 | Mar 13, 2026 |
| Nov 17, 2025 | $0.60 | Dec 5, 2025 |
| Aug 11, 2025 | $0.60 | Aug 29, 2025 |
| May 29, 2025 | $0.50 | Jun 17, 2025 |
| Feb 24, 2025 | $0.50 | Mar 14, 2025 |
| Nov 18, 2024 | $0.50 | Dec 6, 2024 |
Short interest
- Shares sold short
- 653,250
- Days to cover
- 5.40
- Change vs previous report
- +15.7%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- May 12, 2005
- 2-for-1
- Nov 12, 1981
- 2-for-1